Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics

Glycoscience & Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles